Ignite Creation Date:
2024-05-05 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00407303
Status:
COMPLETED
Last Update Posted:
2016-07-21
First Post:
2006-12-01
Brief Title:
Safety and Efficacy of Obatoclax Mesylate GX15-070MS in Combination With Bortezomib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma MCL
Sponsor:
Gemin X
Organization:
Teva Branded Pharmaceutical Products RD Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-10
Start Date Type:
None
Primary Completion Date:
2009-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-11
Completion Date Type:
ACTUAL
First Submit Date:
2006-12-01
First Submit QC Date:
December 4 2006
Study First Post Date:
2006-12-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2013-08-16
Disp First Submit QC Date:
August 16 2013
Disp First Post Date:
2013-08-26
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2016-07-19
Last Update Post Date:
2016-07-21
Last Update Post Date Type:
ESTIMATED